Christoph Wenger
Member R & D Team
R & D
GATC BIOTECH
Germany
Biography
Dr. Wenger studied biotechnology at the University of Braunschweig and obtained his Ph.D. at the University Hospital of Ulm in 2000. His main research interest as a Ph.D. student and subsequently as a post-doctoral fellow at the University Hospital of Ulm was the molecular biology of pancreatic cancer.From 2001 to 2008, Dr. Wenger was employed at CyBio AG in Jena, where he worked on the development and marketing of laboratory automation solutions. From 2008 to 2012, he performed high-throughput screening for drug discovery at Nycomed GmbH in Konstanz.Dr. Wenger joined GATC Biotech’s R&D team in 2012. His main responsibility in the company is the development of automated procedures for next-generation sequencing solutions.
Research Interest
Biotechnology
